当前位置:首页 - 行情中心 - 君实生物-U(688180) - 财务分析 - 现金流量表

君实生物-U

(688180)

  

流通市值:275.90亿  总市值:369.61亿
流通股本:7.66亿   总股本:10.27亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,025,755,430.011,311,599,772.63740,358,831.821,836,170,338.4
  收到的税费返还35,251,559.5635,251,559.5626,804,625.4210,546,104.09
  收到其他与经营活动有关的现金78,605,078.7257,606,816.4736,256,368.2769,811,541.85
  经营活动现金流入小计2,139,612,068.291,404,458,148.66803,419,825.511,916,527,984.34
  购买商品、接受劳务支付的现金1,329,838,706.42928,536,616.33469,391,325.131,732,587,358.04
  支付给职工以及为职工支付的现金926,704,264.05644,115,292.77292,997,853.31,216,708,662.84
  支付的各项税费89,588,618.4353,955,675.3927,815,876.7589,149,699.75
  支付其他与经营活动有关的现金136,890,747.56107,238,897.5137,545,966.83311,923,473.25
  经营活动现金流出小计2,483,022,336.461,733,846,482827,751,022.013,350,369,193.88
  经营活动产生的现金流量净额-343,410,268.17-329,388,333.34-24,331,196.5-1,433,841,209.54
二、投资活动产生的现金流量:
  收回投资收到的现金1,680,000,0001,180,000,000481,065,293.221,901,811,816.6
  取得投资收益收到的现金7,390,735.15,104,981.681,781,547.959,430,216.08
  处置固定资产、无形资产和其他长期资产收回的现金净额8,016,042.58,016,042.53801,865,000
  收到的其他与投资活动有关的现金23,242,429.114,493,280.737,546,867.6944,160,556.11
  投资活动现金流入小计1,718,649,206.71,207,614,304.91490,394,088.861,957,267,588.79
  购建固定资产、无形资产和其他长期资产支付的现金509,553,908.28313,755,421.96161,199,762.48690,987,533.01
  投资支付的现金2,096,966,746.751,425,794,592649,000,0002,159,000,000
  支付其他与投资活动有关的现金20,918,197.3120,918,197.3121,820,04162,189.34
  投资活动现金流出小计2,627,438,852.341,760,468,211.27832,019,803.482,850,049,722.35
  投资活动产生的现金流量净额-908,789,645.64-552,853,906.36-341,625,714.62-892,782,133.56
三、筹资活动产生的现金流量:
  吸收投资收到的现金940,583,277.12939,583,277.12-1,501,566.25
  其中:子公司吸收少数股东投资收到的现金1,000,000--1,501,566.25
  取得借款收到的现金2,502,424,857.041,700,523,498.011,421,654,234.12,306,748,582.68
  收到其他与筹资活动有关的现金90,000,000-676,829.086,350,285.82
  筹资活动现金流入小计3,533,008,134.162,640,106,775.131,422,331,063.182,314,600,434.75
  偿还债务支付的现金1,886,053,666.681,181,404,221.57997,243,377.51,174,018,295.57
  分配股利、利润或偿付利息支付的现金70,493,903.9247,909,712.6623,008,576.1773,790,126.93
  支付其他与筹资活动有关的现金33,889,245.726,428,498.9315,301,114.2643,646,237.27
  筹资活动现金流出小计1,990,436,816.31,255,742,433.161,035,553,067.931,291,454,659.77
  筹资活动产生的现金流量净额1,542,571,317.861,384,364,341.97386,777,995.251,023,145,774.98
四、汇率变动对现金及现金等价物的影响-7,377,820.48376,249.04-791,648.4312,014,641.06
五、现金及现金等价物净增加额282,993,583.57502,498,351.3120,029,435.7-1,291,462,927.06
  加:期初现金及现金等价物余额2,486,679,108.822,486,679,108.822,486,679,108.823,778,142,035.88
  期末现金及现金等价物余额2,769,672,692.392,989,177,460.132,506,708,544.522,486,679,108.82
补充资料:
  净利润--465,673,412.19--1,380,108,858.26
  资产减值准备-50,738,807.77-88,178,776.72
  固定资产和投资性房地产折旧-122,580,963.27-244,829,609.17
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-122,580,963.27-244,829,609.17
  无形资产摊销-16,445,543.77-31,734,565.71
  长期待摊费用摊销-3,679,404.57-11,504,314.2
  处置固定资产、无形资产和其他长期资产的损失--7,583,182.57--12,777,848.8
  固定资产报废损失-170,781.24-938,428.84
  公允价值变动损失--55,513,847.65-47,678,755.74
  财务费用-24,821,791.58-6,033,960.32
  投资损失-20,282,414.15-23,553,900.59
  递延所得税--1,870,126.71-16,350,840.82
  其中:递延所得税资产减少--1,870,126.71-16,350,840.82
  存货的减少-10,192,870.84--159,273,263.21
  经营性应收项目的减少-58,824,950.68-54,205,110
  经营性应付项目的增加--120,501,141.3--415,293,504.21
  其他--1,184,653.77--10,673,190.91
  现金的期末余额-2,989,177,460.13-2,486,679,108.82
  减:现金的期初余额-2,486,679,108.82-3,778,142,035.88
  现金及现金等价物的净增加额-502,498,351.31--1,291,462,927.06
公告日期2025-10-292025-08-272025-04-262025-03-28
审计意见(境内)标准无保留意见
TOP↑